Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cancer risk in patients with psoriasis: should we be paying more attention?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ixekizumab for the treatment of psoriasis: an update on new data since first approval

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Microparticles - culprits in the pathogenesis of systemic lupus erythematosus?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Defining success in treating patients with inflammatory bowel disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Co-morbidity in psoriasis: mechanisms and implications for treatment

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effect of Anti-interleukin-17 Treatment on Haemoglobin A1c Levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Dupilumab treatment in two patients with severe allergic contact dermatitis caused by sesquiterpene lactones

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Side effects after artificial hair implants: 2 case reports

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. 'Barrier dysfunction in Atopic newBorns studY' (BABY): protocol of a Danish prospective birth cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Psoriasis is a chronic-immune-mediated disease affecting 2-4% of the western population. The disease is associated with several co-morbidities including an increased risk of cancer. Concerns have been raised whether psoriasis itself, the psoriasis-associated risk factors, or the treatment of psoriasis might lead to an increased risk of cancer.

AREAS COVERED: We reviewed the literature on cancers associated with psoriasis and discuss some of the potential mechanisms behind the observed associations.

EXPERT OPINION: Patients with psoriasis have an increased risk of cancers overall and some site-specific cancers especially non-melanoma skin cancer, lymphoma, and lung cancer. The increased risk is most likely due to a combination of the chronic low-grade inflammation in psoriasis, risk factors for cancer associated with psoriasis, and the treatment of psoriasis. Future research should investigate the contribution of the individual mechanisms. Additionally, multiple new specific immunomodulatory treatments for psoriasis have been introduced during recent years and it is important to monitor and investigate whether these treatments confer an increased risk of cancers. Lastly, as patients with psoriasis have an increased alcohol use, smoke more than the general population and as psoriasis has been linked to obesity, promotion of a healthy lifestyle is key in the prevention of certain cancer types.

OriginalsprogEngelsk
TidsskriftExpert Review of Clinical Immunology
Vol/bind16
Udgave nummer5
Sider (fra-til)479-492
Antal sider14
ISSN1744-666X
DOI
StatusUdgivet - maj 2020

ID: 60481104